Acyclic cyanamide-based inhibitors of cathepsin K
Authors:
- David N. DeatonDDDavid N. Deaton
- Anne M. HassellAHAnne M. Hassell
- Robert B. McFadyenRMRobert B. McFadyen
- Aaron B. MillerAMAaron B. Miller
- Larry R. MillerLMLarry R. Miller
- J. Alan PayneJPJ. Alan Payne
- Lisa M. ShewchukLSLisa M. Shewchuk
- Derril H. WillardDWDerril H. Willard
- Lois L. WrightLWLois L. Wright
- 1 June 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (12) , 3039-3043
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Novel and potent cyclic cyanamide-based cathepsin K inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Referees 2004Knee Surgery, Sports Traumatology, Arthroscopy, 2004
- Exploration of the P2–P3 SAR of aldehyde cathepsin K inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Cathepsin K Inhibitors: Their Potential as Anti-Osteoporosis AgentsProgress in Medicinal Chemistry, 2004
- Exploration of the P1 SAR of aldehyde cathepsin K inhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- Collagenase Activity of Cathepsin K Depends on Complex Formation with Chondroitin SulfateJournal of Biological Chemistry, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Potent and Selective Inhibition of Human Cathepsin K Leads to Inhibition of Bone Resorption In Vivo in a Nonhuman PrimateJournal of Bone and Mineral Research, 2001
- Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and LJournal of Medicinal Chemistry, 2000
- Prediction of in vivo drug metabolism in the human liver from in vitro metabolism dataPharmacology & Therapeutics, 1997